Imatinib Cytogenetic Response Milestones

Assess imatinib TKI response using ELN 2020 milestones: BCR-ABL1 IS below 10% at 3 months, below 1% at 6 months, and below 0.1% (MMR) at 12 months as optimal response benchmarks.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Assess imatinib TKI response using ELN 2020 milestones: BCR-ABL1 IS below 10% at 3 months, below 1% at 6 months, and below 0.1% (MMR) at 12 months as optimal response benchmarks

Each component has a specific meaning:

  • ELN 2020 milestones: BCR-ABL1 IS below 10% at 3 months — The eln 2020 milestones: bcr-abl1 is below 10% at 3 months recorded for the scenario being assessed.
  • Below 1% at 6 months — The below 1% at 6 months recorded for the scenario being assessed.
  • Below 0 — The below 0 recorded for the scenario being assessed.

Note: Interpret the imatinib response result against the thresholds and context described above.

How to Use

Enter the ELN 2020 milestones: BCR-ABL1 IS below 10% at 3 months, below 1% at 6 months, below 0 for the scenario you are assessing. Assess imatinib TKI response using ELN 2020 milestones: BCR-ABL1 IS below 10% at 3 months, below 1% at 6 months, and below 0.1% (MMR) at 12 months as optimal response benchmarks. Use the imatinib response result to inform your calculation.

Related Calculators

CML Sokal Score

Medical Long-tail

CML Euro Score

Medical Long-tail

Frequently Asked Questions